Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients.
about
Systemic antibiotics for treating diabetic foot infectionsDebridement of diabetic foot ulcersAmpicillin/sulbactam: current status in severe bacterial infectionsClinical predictors of treatment failure for diabetic foot infections: data from a prospective trial.Development of a Health-Related Quality of Life Questionnaire (HRQL) for patients with Extremity Soft Tissue Infections (ESTI)Variation in antibiotic treatment for diabetic patients with serious foot infections: a retrospective observational study.Antimicrobial therapy for diabetic foot infections. A practical approach.A systematic review of foot ulcer in patients with Type 2 diabetes mellitus. II: treatment.Evidence-based antibiotic therapy of diabetic foot infections.Pharmacotherapy of lower limb diabetic ulcers.Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations.Issues and dilemmas in the prevention and treatment of pressure ulcers: a review.Diagnosis and treatment of diabetic foot infections.Debridement of diabetic foot ulcers.Rare Case of Aspergillus ochraceus Osteomyelitis of Calcaneus Bone in a Patient with Diabetic Foot UlcersMeropenem in the treatment of complicated skin and soft tissue infectionsAntimicrobial interventions for the management of diabetic foot infections.A systematic approach to diabetic foot infections.Systematic review of antimicrobial treatments for diabetic foot ulcers.Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment.Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA.Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections.A systematic review of the effectiveness of interventions in the management of infection in the diabetic foot.Expert opinion on the management of infections in the diabetic foot.Diagnostics and treatment of the diabetic foot.Evidences and controversies about recurrence of diabetic foot osteomyelitis: a personal view and an illustrated guide for understanding.Intravenous antibiotics used in dermatology.How long to treat with antibiotics following amputation in patients with diabetic foot infections? Are the 2012 IDSA DFI guidelines reasonable?In diabetic foot infections antibiotics are to treat infection, not to heal wounds.Interventions in the management of infection in the foot in diabetes: a systematic review.Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UK.The wound/burn guidelines - 3: Guidelines for the diagnosis and treatment for diabetic ulcer/gangrene.IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes.The risk of seizures among the carbapenems: a meta-analysis.A Current Approach to Diabetic Foot Infections.Outcomes of surgical treatment of diabetic foot osteomyelitis: a series of 185 patients with histopathological confirmation of bone involvement.Second-line treatment of limb-threatening diabetic foot infections with intravenous fosfomycin.Treatment of diabetic foot osteomyelitis: A surgical critique.Clinical characteristics and outcome in 223 diabetic patients with deep foot infections.Efficacy and cost of ampicillin-sulbactam and ticarcillin-clavulanate in the treatment of hospitalized patients with bacterial infections.
P2860
Q24187313-782DAE91-EE14-4E78-9A41-74102F8633F6Q24240958-6436B330-E829-4AA5-A8CF-7CE2806D17C2Q28242374-D8AF25AA-010C-4F35-9CA7-178A5B6F0A82Q31108823-47DA092B-AEFA-40C3-98CC-B01E84D69123Q33260093-C9818829-93C0-4D57-A47D-83685C08A363Q33625956-2E46CFD3-9F8D-4FBB-86DA-726725410F8EQ33694559-27473D13-3878-4B72-BF50-02669DE6B8B0Q33788802-16A02374-CEBA-4EBF-AC7A-23AC89F4D385Q33881703-1BCC5B83-4025-4E49-A3D4-7A543167191FQ33968152-B2DE1037-5306-4540-8E40-682F2FDB4D2AQ34026343-F2E89997-29CD-4B36-A16C-30C8A13E22A4Q34267728-31400C34-28B6-466C-9FE4-2E5A22B1724EQ34357233-3D73F7BA-4C74-4199-8996-7A441E8E1969Q35041888-BDD24EAB-25DF-4B80-9C6D-1BCB2C66A812Q35647268-4B5D6736-8FCF-499A-BC92-DEF4D3E926F2Q35919254-692ACB92-7393-4474-AF7E-2B8A54F616ECQ36066093-54CE4738-EC8E-43A2-906A-F54F4CB5EF1DQ36291357-37C3B0E2-5CBE-4DFE-92A6-83BAD52EB183Q36451493-B6773B35-3C99-4FA3-BF01-89C201644C5CQ37149371-CF87D9EF-01C2-4161-B205-B3F7C584554DQ37274726-4A19E064-B0F1-4765-BCF2-4F1C4EB675F3Q37557606-BD1D40EF-F3DA-4F41-9D11-AC7A485AACDCQ37978286-D9F9309A-64A7-4640-B73F-943F56EECA60Q37978287-600FEF3B-2EEE-436D-946C-7C8C5F47ABB0Q37988404-3440B2F9-90AD-4AFB-8AD7-57FDCC1C7852Q38005890-25F521C9-3340-4057-934A-978B2CDE8569Q38010520-87A4ECD9-A051-4FF6-B9D5-310AD0275425Q38076744-740AA03C-8D79-46C0-B465-F0D6A555B1B5Q38367413-9ECA6E5E-762F-4223-8859-2A6825CF9794Q38582118-18F87311-B268-441D-8EE9-6BE074E6FE7FQ39929915-515EF047-396A-4010-AF7A-3F5B4BC47B71Q40757188-5BBCC99F-02F3-4DFC-948C-D5062382924FQ40991248-6DDE3F91-79EE-47B6-BB81-61C04051D180Q42218823-BF3EC0B9-72A3-40AD-B263-398807DEA7A3Q44516215-923E649B-05AA-4211-B85C-EDA3FA06C2F6Q46416838-B4D0572F-6F94-470A-A270-60D10F58C015Q46832064-1B7D87ED-3184-45BB-A9CE-821ACE17C4C8Q46977577-F61E9C83-EA44-4D60-ABF6-3A0D75F4F9F0Q50920358-8C959FCB-2EAD-4918-BD0F-ECFDFFEAC82FQ53929379-D82D1F1A-FDBF-4BF7-9131-4890764694B5
P2860
Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Use of ampicillin/sulbactam ve ...... fections in diabetic patients.
@en
Use of ampicillin/sulbactam ve ...... fections in diabetic patients.
@nl
type
label
Use of ampicillin/sulbactam ve ...... fections in diabetic patients.
@en
Use of ampicillin/sulbactam ve ...... fections in diabetic patients.
@nl
prefLabel
Use of ampicillin/sulbactam ve ...... fections in diabetic patients.
@en
Use of ampicillin/sulbactam ve ...... fections in diabetic patients.
@nl
P2093
P356
P1476
Use of ampicillin/sulbactam ve ...... fections in diabetic patients.
@en
P2093
Freeman DV
Gibbons GW
Grayson ML
Habershaw GM
Karchmer AW
Pomposelli FB
Rosenblum BI
P304
P356
10.1093/CLINIDS/18.5.683
P407
P577
1994-05-01T00:00:00Z